-
Signature
-
/s/ Karole Morgan-Prager, Attorney-in-Fact
-
Stock symbol
-
BL
-
Transactions as of
-
Sep 30, 2024
-
Transactions value $
-
-$3,483,559
-
Form type
-
4
-
Date filed
-
10/1/2024, 07:37 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BL |
Common Stock |
Options Exercise |
$555K |
+39.6K |
+17.48% |
$14.00 |
266K |
Sep 30, 2024 |
Direct |
F1 |
transaction |
BL |
Common Stock |
Options Exercise |
$639K |
+45.7K |
+17.14% |
$14.00 |
312K |
Sep 30, 2024 |
Direct |
F1 |
transaction |
BL |
Common Stock |
Sale |
-$782K |
-14.4K |
-4.62% |
$54.20 |
298K |
Sep 30, 2024 |
Direct |
F1, F2 |
transaction |
BL |
Common Stock |
Sale |
-$3.74M |
-68K |
-22.85% |
$54.93 |
230K |
Sep 30, 2024 |
Direct |
F1, F3 |
transaction |
BL |
Common Stock |
Sale |
-$160K |
-2.86K |
-1.25% |
$55.78 |
227K |
Sep 30, 2024 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
BL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-39.6K |
-100% |
$0.00 |
0 |
Sep 30, 2024 |
Common Stock |
39.6K |
$14.00 |
Direct |
F1, F5 |
transaction |
BL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-45.7K |
-100% |
$0.00 |
0 |
Sep 30, 2024 |
Common Stock |
45.7K |
$14.00 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: